The drugmaker shed billions of dollars in value after it told investors that widening Journavx’s approval to chronic pain ...

Vertex Pharmaceuticals VRTX reported adjusted earnings of $4.52 per share for the second quarter of 2025, surpassing the ...

BOSTON (AP) — BOSTON (AP) — Vertex Pharmaceuticals Inc. (VRTX) on Monday reported second-quarter profit of $1.03 billion. The Boston-based company said it had net income of $3.99 per share. Earnings, ...

Vertex Pharmaceuticals Inc (VRTX) reports a 12% revenue increase and successful product launches, while addressing challenges ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Jim Handy is an analyst with Objective Analysis who has covered the semiconductor market for a long time, including authoring ...

ZUG, Switzerland and BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

AbbVie Inc reported a robust second quarter for 2025, with adjusted earnings per share of $2.97 and net revenues reaching $15 ...

Roma (3-4-2-1): Svilar; Çelik (69' Ghilardi), Mancini, Hermoso; Wesley (69' Rensch), Koné (71' Cristante), El Aynaoui, ...

Banque Cantonale Vaudoise has taken a significant position in Amgen Inc. (AMGN), scooping up 15,432 shares worth about $4.81 ...

Collaboration Revenue: Collaboration revenue was $2.0 million for the second quarter of 2025, compared to $94.7 million for the same period in 2024. This decrease is primarily attributable to the ...